Fluoride

Fluoride

SCHEMBL1897237

CCCCCN1C=CN(C)C1.F

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.34
SIGMAR1 Q99720 2/20 0.34
EBP Q15125 1/20 0.34
PTGS1 P23219 3/20 0.32
PTGS2 P35354 3/20 0.32
MGLL Q99685 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
FAAH O00519 1/20 0.32
GNAI3 P08754 1/20 0.31
GNAO1 P09471 1/20 0.31
GNAI1 P63096 1/20 0.31
DNM1 Q05193 2/20 0.31
TBXAS1 P24557 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
PABPC1 P11940 1/20 0.31
APOBEC3A P31941 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL28178011 0.98 GUSB (0.37) GUSBSIGMAR1EBPPTGS1PTGS2
Fluoride SCHEMBL1895740 0.98 GUSB (0.37) GUSBSIGMAR1EBPPTGS1PTGS2
Fluoride SCHEMBL28177114 0.98 GUSB (0.37) GUSBSIGMAR1EBPPTGS1PTGS2
Fluoride SCHEMBL1897155 0.98 GUSB (0.37) GUSBSIGMAR1EBPPTGS1PTGS2
SCHEMBL372841 0.98 GUSB (0.35) GUSBSIGMAR1EBPPTGS1PTGS2
Fluoride SCHEMBL27855827 0.96 GUSB (0.36) GUSBSIGMAR1EBPPTGS1PTGS2
Fluoride SCHEMBL1899649 0.96 GUSB (0.36) GUSBSIGMAR1EBPPTGS1PTGS2
Fluoride SCHEMBL1896865 0.96 GUSB (0.36) GUSBSIGMAR1EBPPTGS1PTGS2
SCHEMBL4066620 0.96 GUSB (0.38) GUSBSIGMAR1EBPPTGS1PTGS2
SCHEMBL92757 0.96 GUSB (0.38) GUSBSIGMAR1EBPPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116130610-A Graphene-based composite sodium metal negative electrode and preparation method thereof 大连理工大学 2023-05-16 CN claimed
EP-1698606-B1 FLUORINATING AGENT AND METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND USING SAME SUMITOMO CHEMICAL CO (JP) 2013-02-20 EP disclosed
US-7939697-B2 Fluorinating agent and method for producing fluorine-containing compound using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-10 US disclosed
US-20090287025-A1 Fluorinating agent and method for producing fluorine-containing compound using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2009-11-19 US disclosed
US-7569703-B2 Fluorinating agent and method for producing fluorine-containing compound using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-08-04 US disclosed
US-20070135634-A1 Fluorinating agent and method for producing fluorine-containing compound using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-06-14 US disclosed
EP-1698606-A1 FLUORINATING AGENT AND METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND USING SAME Sumitomo Chemical Company, Limited (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135634-A1 Fluorinating agent and method for producing fluorine-containing compound using the same AFF1, AFF2, AFF4 GUSB 3448/4885SIGMAR1 419/4885EBP 2933/4885
US-20090287025-A1 Fluorinating agent and method for producing fluorine-containing compound using the same AFF1, AFF2, AFF4 GUSB 3448/4885SIGMAR1 419/4885EBP 2933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.